Stocktoria
WORK Medical Technology Group LTD WOK
WORK Medical Technology Group LTD financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $9.8M | $11.5M | $13.6M |
| Gross profit | $2.3M | $2.9M | $4.1M |
| R&D expense | $435,311 | $302,511 | $301,644 |
| Income tax | $119,053 | -$125,291 | $47,006 |
| Net income | -$1.1M | -$3.5M | $112,030 |
| EPS (diluted) | $-0.04 | $-0.27 | $0.01 |
| Operating cash flow | $6.2M | -$2.2M | $2.2M |
| Free cash flow | $4.9M | -$11.5M | $1.8M |
| Cash & equivalents | $4.1M | $6.6M | $1.6M |
| Inventory | $2.5M | $3.2M | $4.6M |
| Total assets | $33.2M | $36.3M | $30.0M |
| Total liabilities | $12.0M | $20.2M | $19.0M |
| Shareholders' equity | $21.2M | $16.1M | $11.0M |
Growth · year-over-year · Revenue CAGR -14.8%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | -14.4% | -15.2% | — |
| Net income growth | — | -3217.3% | — |
| EPS growth | — | -2800.0% | — |
| Free cash flow growth | — | -752.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.